Research Article
The Prevalence of Headache in Crohn’s Disease: Single-Center Experience
Table 3
Detailed comparison of different parameters between patients with and without headache in Crohn’s disease group.
| | Headache | | No () | Yes () | (%) | (%) |
| Smoking | 3 (18.7%) | 11 (31.4%) | 0.5 | Extraintestinal involvement | 3 (18.7%) | 13 (37.1%) | 0.3 | Site of involvement in Crohn’s disease | | | | Ileal | 6 (37.5%) | 17 (48.6%) | 0.6 | Ileocolonic | 8 (50%) | 16 (45.7%) | Colonic | 2 (12.5%) | 2 (5.7%) | Types of Crohn’s disease | | | | Inflammatory | 10 (62.5%) | 22 (62.9%) | 0.5 | Fistulating | 2 (12.5%) | 8 (22.9%) | Fibrostenotic | 4 (25%) | 5 (14.3%) | Medications used | | | | Mesalazine | 16 (100%) | 34 (97.1%) | 1 | Steroid | 4 (25%) | 5 (14.3%) | 0.4 | Azathioprine | 10 (62.5%) | 17 (48.6%) | 0.5 | Anti-TNF | 2 (12.5%) | 6 (17.1%) | 1 | CDAI (Mean ± SD) | 73.88 ± 36.99 | 69.14 ± 33.46 | 0.6 |
|
|
Mean ± SD: mean ± standard deviation; CDAI: Crohn’s disease activity index.
|